Steve Shum, Chief Executive Officer at INVO Bioscience, Inc. (INVO), bought 117,770 shares at $0.95 ($112K) on 2022-06-01, disclosed to the SEC on 2022-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.95 | 58,885 | $56K | 50.0% |
| 2 | $0.95 | 58,885 | $56K | 50.0% |
| Total | $0.95 avg | 117,770 | $112K | 100% |
| Filing → |